Search Within

Mark Blaine Geyer

Formats
  1. Meeting Abstract (39)
  2. Journal Article (35)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (2)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Adult Leukemia (85)
  2. Center for Hematologic Malignancies (85)
  3. Department of Medicine (85)
  4. Hematologic Malignancies, Division of (85)
  5. Weinberg Fellows (85)
  6. Epidemiology and Biostatistics (29)

More Groups

People
  1. Jae Park (45)
  2. Martin Tallman (20)
  3. Mikhail Roshal (15)
  4. Renier Brentjens (15)
  5. Andriy Derkach (13)
  6. Lindsey Roeker (13)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (14)
  4. 2022 (6)
  5. 2021 (8)
  6. 2020 (10)

More Years

Publications
  1. Blood (32)
  2. Leukemia and Lymphoma (8)
  3. Blood Advances (5)
  4. Haematologica (3)
  5. Journal of Clinical Oncology (3)
  6. Cytotherapy (2)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Taylor & Francis Group (9)
  3. Elsevier Inc. (6)
  4. American Society of Clinical Oncology (4)
  5. Nature Publishing Group (4)
  6. American Association for Cancer Research (3)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial
    Meeting Abstract

    Geyer, M. B.; Burke, P. W.; King, A. C.; Mauro, M. J.; Tallman, M. S.; Levine, R. L.; Sherr, C. J.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of MRD negativity in adults ages 18-60 with Philadelphia chromosome-negative acute lymphoblastic leukemia and lymphoblastic lymphoma
    Meeting Abstract

    Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Cazacu, M. I.; Vemuri, S.; Tallman, M. S.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells
    Journal Article

    Geyer, M. B.; Manjunath, S. H.; Evans, A. G.; Park, J. H.; Davila, M. L.; Cutler, C. S.; Wang, X.; Wang, Y.; Senechal, B.; Rivière, I.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • A comparison of immune reconstitution following human placenta-derived stem cells (HPDSC) with umbilical cord blood transplantation (UCBT) vs. UCBT alone in pediatric recipients with malignant and non-malignant diseases
    Meeting Abstract

    Sandhu, S.; Flower, A.; Geyer, M.; Harrison, L.; Shi, Q.; Pulsipher, M.; Giller, R.; Morris, E.; Klejmont, L.; Ayello, J.; more...
    Journal of Clinical Immunology (2018)

    Fulltext@MSK | Save
  • Digging deeper in relapsed acute lymphoblastic leukemia: Impact of MRD status on outcome in second remission
    Journal Article

    Geyer, M. B.; Tallman, M. S.
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Clinical and pathological features of B-cell acute lymphoblastic leukemia following maintenance treatment with lenalidomide for multiple myeloma
    Meeting Abstract

    Geyer, M. B.; Shaffer, B. C.; Landau, H.; Hassoun, H.; Famulare, C.; Roshal, M.; Dogan, A.; Arcila, M. E.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis
    Journal Article

    Geyer, M. B.; Hsu, M.; Devlin, S. M.; Tallman, M. S.; Douer, D.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Outcomes of patients 60 and older with ALL: Analysis of the SEER database
    Meeting Abstract

    Geyer, M. B.; Hsu, M.; Devlin, S.; Douer, D.; Park, J. H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Updated results: Phase I trial of autologous CD19-targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Meeting Abstract

    Geyer, M. B.; Park, J. H.; Riviere, I.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save